UPDATE: Piper Cuts Osiris Therapeutics (OSIR) to Neutral After Stock Doubles
Tweet Send to a Friend
(Updated - August 13, 2013 1:44 PM EDT)
Piper Jaffray downgraded Osiris Therapeutics (NASDAQ: OSIR) from Overweight to Neutral ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Piper Jaffray downgraded Osiris Therapeutics (NASDAQ: OSIR) from Overweight to Neutral ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
